Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2019 Sep 26;28(4):449–461. doi: 10.1037/pha0000325

Figure 2.

Figure 2.

Proportion with positive (strongly agree or agree), neutral (somewhat agree or somewhat disagree), and negative (disagree or strongly disagree) agonist attitude as a function of years since problem resolution. Years since problem resolution, modeled continuously, was a significant, unique predictor of positive agonist attitude, controlling for the other significant correlates: race/ethnicity, lifetime AUD medication prescription, lifetime OUD agonist medication prescription, history of inpatient or outpatient AOD treatment, and having been diagnosed with a co-occurring psychiatric disorder.